- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
Patent holdings for IPC class A61P 15/10
Total number of patents in this class: 555
10-year publication summary
|
14
|
38
|
46
|
49
|
47
|
66
|
37
|
40
|
28
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17921 |
25 |
| Initiator Pharma A/S | 22 |
9 |
| Takeda Pharmaceutical Company Limited | 2715 |
8 |
| AstraZeneca AB | 2818 |
7 |
| Pfizer Inc. | 3384 |
7 |
| Kyowa Hakko Bio Co., Ltd. | 286 |
7 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 870 |
7 |
| Futura Medical Developments Limited | 30 |
6 |
| Topadur Pharma AG | 25 |
6 |
| ATIR Holding S.A. | 16 |
5 |
| Activ'inside | 85 |
4 |
| ASKA Pharmaceutical Co., Ltd. | 98 |
4 |
| Banyu Pharmaceutical Co., Ltd. | 44 |
4 |
| Nippon Shinyaku Co., Ltd. | 322 |
4 |
| Shionogi & Co., Ltd. | 873 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 626 |
4 |
| Dicot Pharma AB | 16 |
4 |
| Bristol-myers Squibb Company | 4729 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Dainippon Sumitomo Pharma Co., Ltd. | 167 |
3 |
| Other owners | 431 |